Commercial League Healthcare and Insurance Group is a rare champion grown in the harsh conditions of the Bulgarian transition from command economy to a free market. The company’s success is the result of organic growth, modern knowledge and hard work. Transforming the healthcare system from the ground up and accelerating the national economy was clearly our purpose from the outset. Patient and client satisfaction and physician’s excitement from the integrated healthcare deliveries and modern insurance solutions endorsed Commercial League concept like no analyst ever does. We never participated in M&A or industry clustering as one end of cooperation scale and adopted the very collaborative other end of winning through outsourcing, licensing and divestiture. Many partners, particularly from the multinational Pharma companies, benefit this way big way.

We have never privatized any state pharmacy enterprise or pharmaceutical plant.

Our innovative model of transforming healthcare by improved quality and expanded access ranges from complex generic drug supply to minimal invasive surgery; from reining in costs by processing electronic medical records to employing AI in diagnostics and critical decisions. The group’s business model rests on closely connected in functional integration companies that are always ready for an open race in the marketplace. This model has been evaluated very early as the most innovative and visionary throughout Eastern Europe by independent analysts (click here) and recently in the European insurance industry (click here).

Commercial League’s unique, success–driven, collaborative and inclusive culture is often described as ‘ideas festival in relentless eruption’. Strong multinational and multilingual corporate culture, with no gender pay gap, on an all-inclusive workplace was always essential for our global success. Our employees, 99% with a university degree, feel respected and truly valued. Ever since the first company founded, Commercial League National Pharma Center Inc, or Commercial League Global Pharma Center now, to the present day with offices from Singapore to Zürich and Boston, the group thrived on attracting talent and deeply embedded loyalty of its employees. The last 28 years have provided unequivocal evidence ‘why & how’ an intrinsically valuable resource is our people – with their endless qualification upgrades and re-skilling efforts. Big Pharma as well as the communities we are operating in are all thrilled from our winning strategy and constant turning of purpose into performance. Timely delivery in the market research and healthcare publications, intelligence capabilities and large investments, or setting out public healthcare and insurance debate, all is chiefly a product of purpose-driven varied teams of visionary experts and managers.

Commercial League has conducted numerous successful market penetration campaigns, modernized the Bulgarian and the Balkans pharmaceutical industry, pharmaceutical supply and distribution and is an important partner for the state and the public funds (National Health Insurance Fund, State Reserve) in healthcare development and reform. As a major investor in large-scale projects for upgrading the sector’s infrastructure and general access to modern healthcare, Commercial League has been an instrumental force for change in the periphery of Europe – the only growth engine of the union.

• Health and well-being for everyone is our first priority;
• Respect and honesty towards the individuals, families, businesses and communities we serve;
• High quality of all our products and services is an unconditional requirement;
• Innovation and excellence are our constant pursuits.

In line with our values of honesty and fair business practices, Commercial League has repeatedly taken a stand against corruption (click here).

Our vision is constant innovation and quality in healthcare.

As a leading network of healthcare companies, we use our strategic capabilities and sound ethics to serve every patient by providing high quality healthcare products and services to prolong and improve patients’ lives.

That is why we constantly update our business practices and upgrade our standard operating procedures to comply with and even surpass the latest international standards. Our commitment to quality is what differentiates us from our competitors and makes us the partner of choice for multinational organizations.

Our mission is to promote health for everyone by creating equal access to quality healthcare and pharmaceuticals.

We do so by creating infrastructure, implementing technologies and using education to raise health awareness.

In keeping with our set goals, we have created a powerful organization for consultancy and market intelligence in pharmaceuticals and medical technology. Commercial League controls an influential system of health communication (GP Pharmaceuticals Newsletter) and has entered into numerous contracts for promotion, marketing and distribution – with or without a single channel distribution with leading pharmaceutical multinationals.

Drawing on remarkable brand-building expertise, Commercial League has grown into one of the largest and most highly respected healthcare groups, including pharmaceutical companies on the Balkans and in Eastern Europe.

In the last two decades, our business model has been working to make the companies within the group a most productive sales generator and market penetrator in crisis-stricken, partly paralysed and lagging behind technologically Europe.

In terms of competitiveness and patient & client satisfaction, or by capital adequacy in the insurance sector Commercial League largely outperforms the competition.

We have promoted medical education and developed continued training programs for doctors, enhanced the qualification of medical specialists and implemented therapy and dissemination of scientific and research projects.

We have proven our resilience against unwarranted attacks from competitors and delivered unrivaled returns on a series of large investment. Most importantly, Commercial League has helped to make substantial improvements in Bulgaria and the Balkans’ healthcare and saved thousands of lives in the course of our development. Placement of insurance products in 17 EU member markets is expanding. This business model is unprecedented in the history of European business and based on our record of success, we are poised to grow even further in the future.